BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30488478)

  • 1. β-TrCP upregulates HIF-1 in prostate cancer cells.
    Cohen M; Amir S; Golan M; Ben-Neriah Y; Mabjeesh NJ
    Prostate; 2019 Mar; 79(4):403-413. PubMed ID: 30488478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
    Luo W; Zhong J; Chang R; Hu H; Pandey A; Semenza GL
    J Biol Chem; 2010 Feb; 285(6):3651-3663. PubMed ID: 19940151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.
    Shi Z; Wu X; Ke Y; Wang L
    Dig Dis Sci; 2016 Mar; 61(3):785-94. PubMed ID: 26520111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
    Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
    J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCF
    Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
    Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
    Ju UI; Park JW; Park HS; Kim SJ; Chun YS
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chaperone-dependent ubiquitin ligase CHIP targets HIF-1α for degradation in the presence of methylglyoxal.
    Bento CF; Fernandes R; Ramalho J; Marques C; Shang F; Taylor A; Pereira P
    PLoS One; 2010 Nov; 5(11):e15062. PubMed ID: 21124777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
    Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
    Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
    Qiao Y; Zhang Y; Wang J
    Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin E3 ligase β-TrCP negatively regulates surface protein of hepatitis B virus.
    Tu W; Liu J; Qian F; Zhu L; Li M; Zheng H; Zhu C
    J Med Virol; 2023 Mar; 95(3):e28620. PubMed ID: 36846904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
    Liu J; Zhang C; Zhao Y; Yue X; Wu H; Huang S; Chen J; Tomsky K; Xie H; Khella CA; Gatza ML; Xia D; Gao J; White E; Haffty BG; Hu W; Feng Z
    Nat Commun; 2017 Nov; 8(1):1823. PubMed ID: 29180628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
    Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
    PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1.
    Blees JS; Bokesch HR; Rübsamen D; Schulz K; Milke L; Bajer MM; Gustafson KR; Henrich CJ; McMahon JB; Colburn NH; Schmid T; Brüne B
    PLoS One; 2012; 7(10):e46567. PubMed ID: 23056346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.
    Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T
    J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
    Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
    FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
    Paltoglou S; Roberts BJ
    Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of beta-transducin repeat-containing protein.
    Wei S; Chuang HC; Tsai WC; Yang HC; Ho SR; Paterson AJ; Kulp SK; Chen CS
    Mol Pharmacol; 2009 Jul; 76(1):47-57. PubMed ID: 19372209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.